Search - tctmd.com

Displaying 161 - 180 of 602

Sort: Relevancy | Date

Presentation TCT 2016

TCT 764: Effects of Multielectrode Renal Denervation on Sympathetic Nerve Activity and Insulin Resistance in Metabolic Syndrome

Presenter: Melvin D. Lobo, Adam Witkowski, Vasilios Papademetriou

October 31, 2016

Presentation TCT 2016

TCT 761: Long-term (Three-Year) Safety and Effectiveness From the Global SYMPLICITY Registry of Renal Denervation in a Real World Patient Population With Uncontrolled Hypertension

Presenter: Melvin D. Lobo, Adam Witkowski

October 31, 2016

Presentation TCT 2016

TCT 763: Alcohol-Mediated Renal Denervation Current Status and Future Directions

Presenter: Melvin D. Lobo, Adam Witkowski

October 31, 2016

Presentation TCT 2016

TCT 762: Renal Denervation Treatment With the Symplicity Spyral Multielectrode Catheter: Six-Month Safety and Blood Pressure Outcomes From the Global SYMPLICITY Registry

Presenter: Melvin D. Lobo, Adam Witkowski

October 31, 2016

Presentation TCT 2016

PERFECT: A Prospective Registry Evaluating the Effects of Pan-Pelvic Endovascular Intervention on Erectile Function and Lower Urinary Tract Symptoms

Presenter: Joseph A. Hill, Steven P. Marso, Tzung-Dau Wang

October 31, 2016

Presentation TCT 2016

LIVE-IN-A-BOX CASE DEMONSTRATION: Mesentric Artery Intervention (Fibromuscular Dysplasia)

Presenter: Gary M. Ansel, Michael R. Jaff, D. Christopher Metzger

October 30, 2016

Presentation TCT 2016

Management of Visceral Artery Aneurysms: When to Intervene and How to Do It

Presenter: Gary M. Ansel, Michael R. Jaff, Constantino S. Pena

October 30, 2016

Presentation TCT 2016

Great Debate 1: The Optimal Management of Chronic Mesenteric Ischemia Is Catheter-based Intervention!

Presenter: Gary M. Ansel, Michael R. Jaff, Herbert D. Aronow

October 30, 2016

Presentation TCT 2016

LIVE-IN-A-BOX CASE DEMONSTRATION: Renal Artery Intervention (Fibromuscular Dysplasia)

Presenter: Gary M. Ansel, Michael R. Jaff, D. Christopher Metzger

October 30, 2016

Presentation TCT 2016

Treatment of Renal Artery Fibromuscalar Dysplasia: Indications, Techniques, and Outcomes

Presenter: Gary M. Ansel, Michael R. Jaff, Mehdi H. Shishehbor

October 30, 2016

Presentation TCT 2016

Renal Artery Fibromuscular Dysplasia: Natural History and Treatment

Presenter: Gary M. Ansel, Michael R. Jaff

October 30, 2016

Presentation TCT 2016

Atheroscleotic Renal Artery Intervention: What Are the Remaining Indications?

Presenter: Gary M. Ansel, Michael R. Jaff, Sahil A. Parikh

October 30, 2016

Presentation TCT 2016

TCT 375: Renal Impairment is Primarily Caused by Patient and Procedural Complexity Nationwide Study of Acute Kidney Injury Following Coronary Angiography and Intervention

Presenter: Joseph P. Carrozza Jr, Charles J. Davidson

October 30, 2016

Presentation TCT 2016

TCT 374: Propensity Score Matched Analysis of Acute Kidney Injury Following Percutenous Coronary Intervention with Trans-Radial versus Trans-Femoral Approach

Presenter: Joseph P. Carrozza Jr, Charles J. Davidson

October 30, 2016

Presentation TCT 2016

TCT 546: Imaging and Physiology-Guided Zero Contrast Percutaneous Coronary Intervention in Advanced Chronic Kidney Disease

Presenter: Joseph P. Carrozza Jr, Charles J. Davidson

October 30, 2016

Presentation TCT 2016

Peri-Procedural Planning of Renal Sympathetic Denervation using the ReCor Paradise System

Presenter: Oscar A. Mendiz, Giora Weisz, Philipp Lurz

October 30, 2016

News Daily News

FDA: Vascu-Guard Patch Associated With Bleeding, Death After Carotid Endarterectomy

Yael L. Maxwell

September 02, 2016

News Industry News

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

August 25, 2016

News Daily News

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Yael L. Maxwell

August 10, 2016

Presentation TVT 2016

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

Presenter: Ganesh Manoharan

June 17, 2016

Advertisement

TCT 764: Effects of Multielectrode Renal Denervation on Sympathetic Nerve Activity and Insulin Resistance in Metabolic Syndrome

TCT 761: Long-term (Three-Year) Safety and Effectiveness From the Global SYMPLICITY Registry of Renal Denervation in a Real World Patient Population With Uncontrolled Hypertension

TCT 763: Alcohol-Mediated Renal Denervation Current Status and Future Directions

TCT 762: Renal Denervation Treatment With the Symplicity Spyral Multielectrode Catheter: Six-Month Safety and Blood Pressure Outcomes From the Global SYMPLICITY Registry

PERFECT: A Prospective Registry Evaluating the Effects of Pan-Pelvic Endovascular Intervention on Erectile Function and Lower Urinary Tract Symptoms

LIVE-IN-A-BOX CASE DEMONSTRATION: Mesentric Artery Intervention (Fibromuscular Dysplasia)

Management of Visceral Artery Aneurysms: When to Intervene and How to Do It

Great Debate 1: The Optimal Management of Chronic Mesenteric Ischemia Is Catheter-based Intervention!

LIVE-IN-A-BOX CASE DEMONSTRATION: Renal Artery Intervention (Fibromuscular Dysplasia)

Treatment of Renal Artery Fibromuscalar Dysplasia: Indications, Techniques, and Outcomes

Renal Artery Fibromuscular Dysplasia: Natural History and Treatment

Atheroscleotic Renal Artery Intervention: What Are the Remaining Indications?

TCT 375: Renal Impairment is Primarily Caused by Patient and Procedural Complexity Nationwide Study of Acute Kidney Injury Following Coronary Angiography and Intervention

TCT 374: Propensity Score Matched Analysis of Acute Kidney Injury Following Percutenous Coronary Intervention with Trans-Radial versus Trans-Femoral Approach

TCT 546: Imaging and Physiology-Guided Zero Contrast Percutaneous Coronary Intervention in Advanced Chronic Kidney Disease

Peri-Procedural Planning of Renal Sympathetic Denervation using the ReCor Paradise System

FDA: Vascu-Guard Patch Associated With Bleeding, Death After Carotid Endarterectomy

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content